Solution Spotlight with Datwyler Enabling device innovation through component customisation
12:10 - 12:45
With the continued growth in the therapeutic biologics industry, there are more drug delivery challenges than ever before.
A component suppliers such as Datwyler are experiencing increased demands for customisation. Key to the performance of the integral device is the function of every component and often times, customisation of a single component such as an elastomeric closure, can be a key enabler of device innovation. The mission of the Datwyler engineering team is to drive the smooth and timely transition of products from concept to prototype to mass production - not only for product lines that are proprietary to Datwyler, but also for customer-specific developments.
The flexibility and scalability of our Omniflex technology makes it the only technology that offers a very short iteration loop for customised coated product development and hence offers, in the end, a speed-to-market benefit.
Device innovation possible due to customer specific developments
Support from concept to prototyping to mass production
Omniflex coating technology designed to meet the demands of biologics industry and beyond